OUST · trading date Oct 12, 2026 · previous close $39.88 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$169.38M
Net income
-$60.38M
Total assets
$349.52M
Total liabilities
$87.78M
Stockholders' equity
$261.74M
Cash & equivalents
$67.41M
Operating income
-$74.00M
Operating cash flow
-$39.96M
Capital expenditures
$24.89M
Fiscal year 2025, via 10-K filed 2026-03-02.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-43.7%
Net margin
-35.6%
Free cash flow
-$64.85M
Free cash flow margin
-38.3%
Liabilities / assets
25.1%
Equity / assets
74.9%
CapEx / revenue
14.7%
Operating cash flow / net income
0.66×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
San Francisco, CA 94110
350 TREAT AVENUE
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:19 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.